Abstract Policies & Exceptions

Submitting Your Abstract to Another Meeting

Per ASCO’s Confidentiality Policy, abstracts accepted for publication in a medical journal prior to February 25, 2019, are required to notify ASCO by email. Authors are allowed to submit their abstracts to other meetings after it has been publicly released through ASCO. During the abstract submission process, you will be asked if your abstract has been presented at another major medical meeting, as well as if it has been submitted for publication in a medical journal.

On submission, authors must notify the organizers of the other meeting that the abstract was presented at the ASCO-SITC Clinical Immuno-Oncology Symposium and that ASCO holds the copyright to the abstract. A credit line must be published as follows: “Reused with permission from the American Society of Clinical Oncology (ASCO). This abstract was accepted and previously presented at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium. All rights reserved.” Email us for additional information.

Presentation at Other Cosponsoring Societies’ Meetings

The eligibility of studies submitted to the ASCO-SITC Clinical Immuno-Oncology Symposium for future cosponsoring society Annual Meetings is listed below. In order to submit an abstract to either of these meetings, the submitter must use that meeting’s abstract submitter. 

  • ASCO – A study submitted to the ASCO-SITC Clinical Immuno-Oncology Symposium may also be submitted to the ASCO Annual Meeting. However, the submission of updated data in the new abstract is highly encouraged.  Please note the Scientific Program Committee will take into account the novelty of data during the abstract selection process. 
  • SITC – A study submitted to the ASCO-SITC Clinical Immuno-Oncology Symposium may be submitted to the SITC Annual Meeting. However, the submission of substantially updated data in the new abstract is required in order for it to be considered for presentation.